Independent association of circulating resistin with glomerular filtration rate in the early stages of essential hypertension

Journal of Human Hypertension

Volumn 23, Issue 10, 2009, Pages 668-673

  Dimitriadis, K ^a   Tsioufis, C ^a   Selima, M ^a   Tsiachris, D ^a   Miliou, A ^a   Kasiakogias, A ^a   Andrikou, E ^a   Tousoulis, D ^a   Stefanadis, C ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; LOW DENSITY LIPOPROTEIN; RESISTIN; UREA;

ADULT; AGE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; BODY MASS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE CLASSIFICATION; DISEASE SEVERITY; ESSENTIAL HYPERTENSION; FEMALE; GLOMERULUS FILTRATION RATE; HEART RATE; HUMAN; KIDNEY DYSFUNCTION; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; UREA BLOOD LEVEL; VENOUS BLOOD; WAIST CIRCUMFERENCE;

AGE FACTORS; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY DISEASES; LINEAR MODELS; MALE; MIDDLE AGED; RESISTIN; RISK ASSESSMENT; RISK FACTORS; UP-REGULATION;

EID: 70349440919     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2009.12     Document Type: Article

References (30)

1. Rangwala SM, Lazar ST, Bhat S, Brown EJ, Banerjee RR, Wright CM et al The hormone resistin links obesity to diabetes. Nature 2001; 409: 307-312.
2. Verma S, Li SH, Wang CH, Fedak PW, Li RK, Weisel RD et al. Resistin promotes endothelial cell activation: Further evidence of adipokine-endothelial interaction. Circulation 2003; 108: 736-740.
3. Steppan CM, Lazar MA. The current biology of resistin. J Intern Med 2004; 255: 439-447.
4. Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BL, Murphy LJ. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 2003; 149: 331-335.
5. Norata GD, Ongari M, Garlaschelli K, Raselli S, Grigore L, Catapano AL. Plasma resistin levels correlate with determinants of the metabolic syndrome. Eur J Endocrinol 2007; 156: 279-284.
6. Ohmori R, Momiyama Y, Kato R, Taniguchi H, Ogura M, Ayaori M et al Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease. J Am Coll Cardiol 2005; 46: 379-380.
7. McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, Kumar S. Resistin, central obesity, and type 2 diabetes. Lancet 2002; 359: 46-47.
8. Malyszko J, Malyszko JS, Pawlak K, Mysliwiec M. Resistin, a new adipokine, is related to inflammation and renal function in kidney allograft recipients. Transplant Proc 2006; 38: 3434-3436.
9. Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV et al. Resistin/Fizz3 expression in obesity and peroxisome proliferator- activated receptor y in humans. Diabetes 2001; 50 2199-2202.
10. Zhang JL, Qin YW, Zheng X, Qiu JL, Zou DJ. Serum resistin level in essential hypertension patients with different glucose tolerance. Diabet Med 2003; 20: 828-831.
11. Furuhashi M, Ura N, Higashiura K, Murakami H, Shimamoto K. Circulating resistin levels in essential hypertension. Clin Endocrinol 2003; 59: 507-510.
12. Takata Y, Osawa H, Kurata M, Kurokawa M, Yamauchi J, Ochi M et al. Hyperresistinemia is associated with coexistence of hypertension and type 2 diabetes. Hypertension 2008; 51: 534-539.
13. Shin HJ, Park S, Yoon SJ, Cho DK, Kim JS, Ko YG et al. Association between serum resistin and carotid intima media thickness in hypertension patients. Int J Cardiol 2008; 125: 79-84.
14. Axelsson J, Bergsten A, Qureshi AR, Heimbürger O, Bárány P, Lönnqvist F et al. Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int 2006; 69: 596-604.
15. Ellington AA, Malik AR, Klee GG, Turner ST, Rule AD, Mosley Jr TH et al. Association of plasma resistin with glomerular filtration rate and albuminuria in hypertensive adults. Hypertension 2007; 50 708-714.
16. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. Management of Arterial Hypertension of the European Society of Hypertension et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-1187.
17. Tsioufis C, Stefanadis C, Antoniadis D, Kallikazaros I, Zambaras P, Pitsavos C et al. Absence of any significant effects of circadian blood pressure variations on carotid artery elastic properties in essential hypertensive subjects. J Hum Hypertens 2000; 14: 813-818.
18. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 2002; 39: S1-S246.
19. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H et al. Recommendations for quantitation of the left ventricular dimensions by two-dimensional echocardiography. American Society of Echocardiography Committee on standards, subcommittee on quantitation of the two-dimensional echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-367.
20. Kielstein JT, Becker B, Graf S, Brabant G, Haller H, Fliser D. Increased resistin blood levels are not associated with insulin resistance in patients with renal disease. Am J Kidney Dis 2003; 42: 62-66.
21. Risch L, Saely C, Hoefle G, Rein P, Langer P, Gouya G et al. Relationship between glomerular filtration rate and the adipokines adiponectin, resistin and leptin in coronary patients with predominantly normal or mildly impaired renal function. Clin Chim Acta 2007; 376: 108-113.
22. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW et al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-147.
23. Perticone F, Maio R, Tripepi G, Zoccali C. Endothelial dysfunction and mild renal insufficiency in essential hypertension. Circulation 2004; 110: 821-825.
24. Waldmann TA, Strober W, Mogienlnicki RP. The renal handling of low molecular weight proteins. II. Disorders of serum protein catabolism in patients with tubular proteinuria, the nephrotic syndrome or uremia. J Clin Invest 1972; 51: 2162-2174.
25. Tsioufis C, Dimitriadis K, Chatzis D, Stougianos P, Kakavas A, Vlasseros I et al. Relation of microalbuminuria to adiponectin and augmented C-reactive protein levels in men with essential hypertension. Am J Cardiol 2005; 96: 946-951.
26. Tsioufis C, Dimitriadis K, Taxiarchou E, Vasiliadou C, Charzoulakis G, Tousoulis D et al. Diverse associations of microalbuminuria with C-reactive protein, interleukin- 18 and soluble CD 40 ligand in male essential hypertensive subjects. Am J Hypertens 2006; 19: 462-466.
27. Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol 2005; 174: 5789-5795.
28. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005; 111: 932-939.
29. Jung HS, Park KH, Cho YM, Chung SS, Cho HJ, Cho SY et al. Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovasc Res 2006; 69: 76-85.
30. Verdecchia P, Schillaci G, Borgioni C, Giucci A, Pede S, Porcellati C. Ambulatory pulse pressure: A potent predictor of total cardiovascular risk in hypertension. Hypertension 1998; 32: 983-988.